-The Hindu Business Line The PM Krishi Sinchai Yojana smacks of poor watershed planning. As with earlier schemes, accountability is absent The launch of any new scheme by the government always creates a sense of déjà vu. First, priorities, plans and programmes constantly change depending upon who’s in power at the Centre; second, schemes, new or old, deliver identical outcomes. The Ganga Action Plan (GAP), Accelerated Irrigation Benefit Programme (AIBP), MNREGA were all...

Two recent reports show that this social sector scheme has had a causal impact in improving lives, especially for women and children Fourteen million people escaped falling into poverty under the world’s largest anti-poverty programme, the Mahatma Gandhi National Rural Employment Guarantee Act (MGNREGA). In 10 years of its existence, the scheme reduced poverty by 32 per cent. Recent data also shows that more women are drawing cash incomes, more children...

-The Hindu Business Line New Delhi: All India Kisan Sabha, the farmers’ outfit of CPI (M), has decided to hold a protest of the family members of farmers who committed suicide in the last one year. Families of about 100 farmers, who committed suicide, will sit in front of Parliament to protest the policies of the Narendra Modi Government on Monday. Alarming rise CPI (M) Polit Bureau member and AIKS General Secretary Hannan...

-Economic and Political Weekly There are basic methodological and conceptual problems with recent research that ends up arguing that private school education is more effective than public education. Such findings have obvious policy implications but it is critical that research that informs policy is based on a correct reading of facts, keeping the larger vision of education in mind. Recent research into the cost effectiveness of public education vis-à-vis private education concludes...

-The Times of India MUMBAI/NEW DELHI: Medicines widely used to treat diabetes, infections, pain and digestive disorders will cost 5-40% less with immediate effect, with the drug price regulator issuing an order to fix the prices of 39-odd formulations. The National Pharmaceutical Pricing Authority's (NPPA) order, issued on Wednesday, includes drug combinations such as ciprofloxacin hydrochloride, cefotaxime, paracetamol, domperidone and metformin + glimepiride and amoxycillin + potassium clavulanate. These drugs and combinations are...